Theriva Biologics TOVX
NYSE TOVX
$0.23 +0.01 (+2.40%)
As of: Oct 1, 2026 · 3:56 PM EDT

Theriva Biologics (TOVX) Long-Term Debt Repayments (2010 - 2025)

Updated

Theriva Biologics (TOVX) reported Long-Term Debt Repayments of $56,000 for Q1 2025.

Analysis

Theriva Biologics (TOVX) Long-Term Debt Repayments (2010 - 2025) Analysis & Trends

For FY2024, Theriva Biologics posted Long-Term Debt Repayments of $67,000, down 10.7% from FY2023.

  • By year, Long-Term Debt Repayments came in at $75,000 in FY2023 (-94.5%) and $1.38 million in FY2022.
  • The Q1 2025 figure ranks as the highest quarterly Long-Term Debt Repayments since Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.00 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.45 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 17.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Theriva Biologics 10.56 Mn 10.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 56,000.00
Jun 30, 2023 20,000.00
Mar 31, 2023 55,000.00
Mar 31, 2022 1.38 Mn
Sep 30, 2010 2,375.00
API Access

Theriva Biologics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=TOVX&period=max&api_key=YOUR_API_KEY